nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—CYP2A6—prostate cancer	0.162	0.464	CbGaD
Sevoflurane—CYP2E1—prostate cancer	0.115	0.329	CbGaD
Sevoflurane—CYP3A4—prostate cancer	0.0726	0.207	CbGaD
Sevoflurane—ALB—Abiraterone—prostate cancer	0.0358	0.111	CbGbCtD
Sevoflurane—CYP2E1—Estrone—prostate cancer	0.0268	0.0828	CbGbCtD
Sevoflurane—CYP2B6—Estrone—prostate cancer	0.0264	0.0817	CbGbCtD
Sevoflurane—ALB—Estrone—prostate cancer	0.0259	0.08	CbGbCtD
Sevoflurane—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0258	0.0797	CbGbCtD
Sevoflurane—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0236	0.0728	CbGbCtD
Sevoflurane—CYP2E1—Mitoxantrone—prostate cancer	0.0159	0.0492	CbGbCtD
Sevoflurane—ALB—Estradiol—prostate cancer	0.0149	0.046	CbGbCtD
Sevoflurane—CYP3A4—Bicalutamide—prostate cancer	0.0136	0.0419	CbGbCtD
Sevoflurane—ALB—Prednisone—prostate cancer	0.0128	0.0395	CbGbCtD
Sevoflurane—CYP3A4—Estramustine—prostate cancer	0.0126	0.0389	CbGbCtD
Sevoflurane—CYP3A4—Flutamide—prostate cancer	0.0112	0.0347	CbGbCtD
Sevoflurane—CYP3A4—Abiraterone—prostate cancer	0.0112	0.0347	CbGbCtD
Sevoflurane—CYP2E1—Etoposide—prostate cancer	0.01	0.031	CbGbCtD
Sevoflurane—CYP3A4—Cabazitaxel—prostate cancer	0.00831	0.0257	CbGbCtD
Sevoflurane—CYP3A4—Estrone—prostate cancer	0.00812	0.0251	CbGbCtD
Sevoflurane—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00724	0.0224	CbGbCtD
Sevoflurane—CYP2B6—Doxorubicin—prostate cancer	0.00676	0.0209	CbGbCtD
Sevoflurane—CYP3A4—Conjugated Estrogens—prostate cancer	0.00531	0.0164	CbGbCtD
Sevoflurane—CYP3A4—Mitoxantrone—prostate cancer	0.00483	0.0149	CbGbCtD
Sevoflurane—CYP3A4—Estradiol—prostate cancer	0.00466	0.0144	CbGbCtD
Sevoflurane—CYP3A4—Prednisone—prostate cancer	0.00401	0.0124	CbGbCtD
Sevoflurane—CYP3A4—Etoposide—prostate cancer	0.00305	0.00941	CbGbCtD
Sevoflurane—CYP3A4—Docetaxel—prostate cancer	0.00279	0.00861	CbGbCtD
Sevoflurane—KCNK2—prostate gland—prostate cancer	0.00256	0.0565	CbGeAlD
Sevoflurane—CYP3A4—Doxorubicin—prostate cancer	0.00208	0.00642	CbGbCtD
Sevoflurane—KCNK10—renal system—prostate cancer	0.00186	0.0412	CbGeAlD
Sevoflurane—ND1—prostate gland—prostate cancer	0.00171	0.0378	CbGeAlD
Sevoflurane—KCNK3—renal system—prostate cancer	0.00168	0.0372	CbGeAlD
Sevoflurane—CYP2E1—urine—prostate cancer	0.00153	0.0338	CbGeAlD
Sevoflurane—ATP5D—prostate gland—prostate cancer	0.00138	0.0305	CbGeAlD
Sevoflurane—ATP2C1—prostate gland—prostate cancer	0.00136	0.0301	CbGeAlD
Sevoflurane—GABRP—prostate gland—prostate cancer	0.00133	0.0295	CbGeAlD
Sevoflurane—CYP3A4—urine—prostate cancer	0.00123	0.0272	CbGeAlD
Sevoflurane—ATP5D—seminal vesicle—prostate cancer	0.00117	0.0258	CbGeAlD
Sevoflurane—ND1—renal system—prostate cancer	0.00117	0.0258	CbGeAlD
Sevoflurane—CYP2A6—prostate gland—prostate cancer	0.00116	0.0257	CbGeAlD
Sevoflurane—ATP2C1—seminal vesicle—prostate cancer	0.00115	0.0254	CbGeAlD
Sevoflurane—KCNK2—testis—prostate cancer	0.00113	0.0249	CbGeAlD
Sevoflurane—GABRE—prostate gland—prostate cancer	0.00102	0.0225	CbGeAlD
Sevoflurane—CYP2A6—seminal vesicle—prostate cancer	0.000983	0.0217	CbGeAlD
Sevoflurane—ATP5D—renal system—prostate cancer	0.00094	0.0208	CbGeAlD
Sevoflurane—ATP2C1—renal system—prostate cancer	0.000928	0.0205	CbGeAlD
Sevoflurane—ATP5D—urethra—prostate cancer	0.000923	0.0204	CbGeAlD
Sevoflurane—ATP2C1—urethra—prostate cancer	0.000911	0.0201	CbGeAlD
Sevoflurane—GABRP—urethra—prostate cancer	0.000893	0.0197	CbGeAlD
Sevoflurane—ND1—bone marrow—prostate cancer	0.000882	0.0195	CbGeAlD
Sevoflurane—GRIA1—testis—prostate cancer	0.000876	0.0194	CbGeAlD
Sevoflurane—GABRB3—prostate gland—prostate cancer	0.000863	0.0191	CbGeAlD
Sevoflurane—GABRE—seminal vesicle—prostate cancer	0.000861	0.019	CbGeAlD
Sevoflurane—GABRG3—testis—prostate cancer	0.000849	0.0188	CbGeAlD
Sevoflurane—KCNK2—lymph node—prostate cancer	0.000816	0.018	CbGeAlD
Sevoflurane—ND1—testis—prostate cancer	0.000754	0.0167	CbGeAlD
Sevoflurane—ATP5D—bone marrow—prostate cancer	0.000711	0.0157	CbGeAlD
Sevoflurane—GABRD—testis—prostate cancer	0.000703	0.0155	CbGeAlD
Sevoflurane—ATP2C1—bone marrow—prostate cancer	0.000701	0.0155	CbGeAlD
Sevoflurane—GABRE—urethra—prostate cancer	0.000682	0.0151	CbGeAlD
Sevoflurane—GABRA5—testis—prostate cancer	0.000653	0.0144	CbGeAlD
Sevoflurane—GABRA3—testis—prostate cancer	0.000607	0.0134	CbGeAlD
Sevoflurane—ATP5D—testis—prostate cancer	0.000607	0.0134	CbGeAlD
Sevoflurane—ATP2C1—testis—prostate cancer	0.0006	0.0133	CbGeAlD
Sevoflurane—CYP2E1—prostate gland—prostate cancer	0.000549	0.0121	CbGeAlD
Sevoflurane—ND1—lymph node—prostate cancer	0.000546	0.0121	CbGeAlD
Sevoflurane—GABRB2—testis—prostate cancer	0.000495	0.0109	CbGeAlD
Sevoflurane—CYP2E1—seminal vesicle—prostate cancer	0.000465	0.0103	CbGeAlD
Sevoflurane—GABRE—testis—prostate cancer	0.000449	0.00992	CbGeAlD
Sevoflurane—ATP5D—lymph node—prostate cancer	0.00044	0.00973	CbGeAlD
Sevoflurane—ATP2C1—lymph node—prostate cancer	0.000435	0.00961	CbGeAlD
Sevoflurane—ALB—testis—prostate cancer	0.000409	0.00904	CbGeAlD
Sevoflurane—CYP2B6—renal system—prostate cancer	0.000399	0.00882	CbGeAlD
Sevoflurane—GABRB3—testis—prostate cancer	0.00038	0.00841	CbGeAlD
Sevoflurane—CYP2E1—renal system—prostate cancer	0.000374	0.00827	CbGeAlD
Sevoflurane—CYP2E1—urethra—prostate cancer	0.000368	0.00813	CbGeAlD
Sevoflurane—GABRA2—lymph node—prostate cancer	0.000328	0.00725	CbGeAlD
Sevoflurane—GABRE—lymph node—prostate cancer	0.000325	0.00719	CbGeAlD
Sevoflurane—CYP3A4—renal system—prostate cancer	0.000301	0.00666	CbGeAlD
Sevoflurane—ALB—lymph node—prostate cancer	0.000296	0.00655	CbGeAlD
Sevoflurane—CYP2B6—testis—prostate cancer	0.000258	0.0057	CbGeAlD
Sevoflurane—CYP2E1—testis—prostate cancer	0.000242	0.00535	CbGeAlD
Sevoflurane—Dysgeusia—Capecitabine—prostate cancer	8.82e-05	0.000522	CcSEcCtD
Sevoflurane—Nausea—Conjugated Estrogens—prostate cancer	8.75e-05	0.000518	CcSEcCtD
Sevoflurane—Urticaria—Mitoxantrone—prostate cancer	8.73e-05	0.000516	CcSEcCtD
Sevoflurane—Hypersensitivity—Estradiol—prostate cancer	8.69e-05	0.000514	CcSEcCtD
Sevoflurane—Body temperature increased—Mitoxantrone—prostate cancer	8.69e-05	0.000514	CcSEcCtD
Sevoflurane—Hypotension—Etoposide—prostate cancer	8.54e-05	0.000505	CcSEcCtD
Sevoflurane—Asthenia—Estradiol—prostate cancer	8.46e-05	0.0005	CcSEcCtD
Sevoflurane—Dysuria—Epirubicin—prostate cancer	8.42e-05	0.000498	CcSEcCtD
Sevoflurane—Angiopathy—Prednisone—prostate cancer	8.37e-05	0.000495	CcSEcCtD
Sevoflurane—Syncope—Docetaxel—prostate cancer	8.35e-05	0.000494	CcSEcCtD
Sevoflurane—Pruritus—Estradiol—prostate cancer	8.34e-05	0.000493	CcSEcCtD
Sevoflurane—Immune system disorder—Prednisone—prostate cancer	8.33e-05	0.000492	CcSEcCtD
Sevoflurane—Arrhythmia—Prednisone—prostate cancer	8.24e-05	0.000487	CcSEcCtD
Sevoflurane—Loss of consciousness—Docetaxel—prostate cancer	8.18e-05	0.000484	CcSEcCtD
Sevoflurane—Pancreatitis—Doxorubicin—prostate cancer	8.17e-05	0.000483	CcSEcCtD
Sevoflurane—Dyspnoea—Etoposide—prostate cancer	8.15e-05	0.000482	CcSEcCtD
Sevoflurane—Hyperglycaemia—Epirubicin—prostate cancer	8.13e-05	0.000481	CcSEcCtD
Sevoflurane—Somnolence—Etoposide—prostate cancer	8.13e-05	0.00048	CcSEcCtD
Sevoflurane—Cough—Docetaxel—prostate cancer	8.12e-05	0.00048	CcSEcCtD
Sevoflurane—Hypersensitivity—Mitoxantrone—prostate cancer	8.1e-05	0.000479	CcSEcCtD
Sevoflurane—Syncope—Capecitabine—prostate cancer	8.08e-05	0.000478	CcSEcCtD
Sevoflurane—Mental disorder—Prednisone—prostate cancer	8.08e-05	0.000478	CcSEcCtD
Sevoflurane—Convulsion—Docetaxel—prostate cancer	8.06e-05	0.000477	CcSEcCtD
Sevoflurane—Hypertension—Docetaxel—prostate cancer	8.04e-05	0.000475	CcSEcCtD
Sevoflurane—Malnutrition—Prednisone—prostate cancer	8.03e-05	0.000475	CcSEcCtD
Sevoflurane—Chest pain—Docetaxel—prostate cancer	7.92e-05	0.000469	CcSEcCtD
Sevoflurane—Loss of consciousness—Capecitabine—prostate cancer	7.92e-05	0.000468	CcSEcCtD
Sevoflurane—Renal failure—Epirubicin—prostate cancer	7.9e-05	0.000467	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Etoposide—prostate cancer	7.89e-05	0.000467	CcSEcCtD
Sevoflurane—Asthenia—Mitoxantrone—prostate cancer	7.88e-05	0.000466	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	7.87e-05	0.000465	CcSEcCtD
Sevoflurane—Cough—Capecitabine—prostate cancer	7.86e-05	0.000465	CcSEcCtD
Sevoflurane—Jaundice—Epirubicin—prostate cancer	7.83e-05	0.000463	CcSEcCtD
Sevoflurane—Pain—Etoposide—prostate cancer	7.82e-05	0.000462	CcSEcCtD
Sevoflurane—Conjunctivitis—Epirubicin—prostate cancer	7.81e-05	0.000462	CcSEcCtD
Sevoflurane—Dizziness—Estradiol—prostate cancer	7.8e-05	0.000461	CcSEcCtD
Sevoflurane—Dysuria—Doxorubicin—prostate cancer	7.8e-05	0.000461	CcSEcCtD
Sevoflurane—Hypertension—Capecitabine—prostate cancer	7.78e-05	0.00046	CcSEcCtD
Sevoflurane—Dry mouth—Docetaxel—prostate cancer	7.75e-05	0.000458	CcSEcCtD
Sevoflurane—Chest pain—Capecitabine—prostate cancer	7.67e-05	0.000454	CcSEcCtD
Sevoflurane—Confusional state—Docetaxel—prostate cancer	7.66e-05	0.000453	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	7.62e-05	0.00045	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Epirubicin—prostate cancer	7.6e-05	0.000449	CcSEcCtD
Sevoflurane—Oedema—Docetaxel—prostate cancer	7.6e-05	0.000449	CcSEcCtD
Sevoflurane—Anaphylactic shock—Docetaxel—prostate cancer	7.6e-05	0.000449	CcSEcCtD
Sevoflurane—Feeling abnormal—Etoposide—prostate cancer	7.53e-05	0.000445	CcSEcCtD
Sevoflurane—Hyperglycaemia—Doxorubicin—prostate cancer	7.52e-05	0.000445	CcSEcCtD
Sevoflurane—Dry mouth—Capecitabine—prostate cancer	7.5e-05	0.000444	CcSEcCtD
Sevoflurane—Vomiting—Estradiol—prostate cancer	7.5e-05	0.000443	CcSEcCtD
Sevoflurane—Shock—Docetaxel—prostate cancer	7.47e-05	0.000442	CcSEcCtD
Sevoflurane—Nervous system disorder—Docetaxel—prostate cancer	7.45e-05	0.00044	CcSEcCtD
Sevoflurane—Thrombocytopenia—Docetaxel—prostate cancer	7.44e-05	0.00044	CcSEcCtD
Sevoflurane—Rash—Estradiol—prostate cancer	7.44e-05	0.00044	CcSEcCtD
Sevoflurane—Dermatitis—Estradiol—prostate cancer	7.43e-05	0.000439	CcSEcCtD
Sevoflurane—Confusional state—Capecitabine—prostate cancer	7.42e-05	0.000438	CcSEcCtD
Sevoflurane—Tachycardia—Docetaxel—prostate cancer	7.41e-05	0.000438	CcSEcCtD
Sevoflurane—Headache—Estradiol—prostate cancer	7.39e-05	0.000437	CcSEcCtD
Sevoflurane—Skin disorder—Docetaxel—prostate cancer	7.38e-05	0.000436	CcSEcCtD
Sevoflurane—Agitation—Prednisone—prostate cancer	7.38e-05	0.000436	CcSEcCtD
Sevoflurane—Oedema—Capecitabine—prostate cancer	7.35e-05	0.000435	CcSEcCtD
Sevoflurane—Bradycardia—Epirubicin—prostate cancer	7.34e-05	0.000434	CcSEcCtD
Sevoflurane—Renal failure—Doxorubicin—prostate cancer	7.31e-05	0.000432	CcSEcCtD
Sevoflurane—Urticaria—Etoposide—prostate cancer	7.26e-05	0.000429	CcSEcCtD
Sevoflurane—Haemoglobin—Epirubicin—prostate cancer	7.25e-05	0.000429	CcSEcCtD
Sevoflurane—Jaundice—Doxorubicin—prostate cancer	7.25e-05	0.000428	CcSEcCtD
Sevoflurane—Shock—Capecitabine—prostate cancer	7.24e-05	0.000428	CcSEcCtD
Sevoflurane—Body temperature increased—Etoposide—prostate cancer	7.23e-05	0.000427	CcSEcCtD
Sevoflurane—Conjunctivitis—Doxorubicin—prostate cancer	7.23e-05	0.000427	CcSEcCtD
Sevoflurane—Nervous system disorder—Capecitabine—prostate cancer	7.21e-05	0.000426	CcSEcCtD
Sevoflurane—Hepatitis—Epirubicin—prostate cancer	7.21e-05	0.000426	CcSEcCtD
Sevoflurane—Haemorrhage—Epirubicin—prostate cancer	7.21e-05	0.000426	CcSEcCtD
Sevoflurane—Thrombocytopenia—Capecitabine—prostate cancer	7.2e-05	0.000426	CcSEcCtD
Sevoflurane—Syncope—Prednisone—prostate cancer	7.2e-05	0.000426	CcSEcCtD
Sevoflurane—Tachycardia—Capecitabine—prostate cancer	7.18e-05	0.000424	CcSEcCtD
Sevoflurane—Pharyngitis—Epirubicin—prostate cancer	7.16e-05	0.000423	CcSEcCtD
Sevoflurane—Skin disorder—Capecitabine—prostate cancer	7.14e-05	0.000422	CcSEcCtD
Sevoflurane—Urinary tract disorder—Epirubicin—prostate cancer	7.12e-05	0.000421	CcSEcCtD
Sevoflurane—Hypotension—Docetaxel—prostate cancer	7.1e-05	0.00042	CcSEcCtD
Sevoflurane—Urethral disorder—Epirubicin—prostate cancer	7.07e-05	0.000418	CcSEcCtD
Sevoflurane—Loss of consciousness—Prednisone—prostate cancer	7.05e-05	0.000417	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Doxorubicin—prostate cancer	7.03e-05	0.000416	CcSEcCtD
Sevoflurane—Nausea—Estradiol—prostate cancer	7e-05	0.000414	CcSEcCtD
Sevoflurane—Vomiting—Mitoxantrone—prostate cancer	6.99e-05	0.000413	CcSEcCtD
Sevoflurane—Convulsion—Prednisone—prostate cancer	6.95e-05	0.000411	CcSEcCtD
Sevoflurane—Hypertension—Prednisone—prostate cancer	6.93e-05	0.00041	CcSEcCtD
Sevoflurane—Rash—Mitoxantrone—prostate cancer	6.93e-05	0.00041	CcSEcCtD
Sevoflurane—Dermatitis—Mitoxantrone—prostate cancer	6.92e-05	0.000409	CcSEcCtD
Sevoflurane—Headache—Mitoxantrone—prostate cancer	6.88e-05	0.000407	CcSEcCtD
Sevoflurane—Hypotension—Capecitabine—prostate cancer	6.87e-05	0.000406	CcSEcCtD
Sevoflurane—Insomnia—Docetaxel—prostate cancer	6.87e-05	0.000406	CcSEcCtD
Sevoflurane—Bradycardia—Doxorubicin—prostate cancer	6.79e-05	0.000402	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	6.79e-05	0.000401	CcSEcCtD
Sevoflurane—Dyspnoea—Docetaxel—prostate cancer	6.77e-05	0.0004	CcSEcCtD
Sevoflurane—Somnolence—Docetaxel—prostate cancer	6.75e-05	0.000399	CcSEcCtD
Sevoflurane—Hypersensitivity—Etoposide—prostate cancer	6.73e-05	0.000398	CcSEcCtD
Sevoflurane—Haemoglobin—Doxorubicin—prostate cancer	6.71e-05	0.000397	CcSEcCtD
Sevoflurane—Cardiac disorder—Epirubicin—prostate cancer	6.69e-05	0.000396	CcSEcCtD
Sevoflurane—Hepatitis—Doxorubicin—prostate cancer	6.67e-05	0.000395	CcSEcCtD
Sevoflurane—Haemorrhage—Doxorubicin—prostate cancer	6.67e-05	0.000395	CcSEcCtD
Sevoflurane—Insomnia—Capecitabine—prostate cancer	6.65e-05	0.000393	CcSEcCtD
Sevoflurane—Pharyngitis—Doxorubicin—prostate cancer	6.62e-05	0.000392	CcSEcCtD
Sevoflurane—Urinary tract disorder—Doxorubicin—prostate cancer	6.59e-05	0.00039	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Docetaxel—prostate cancer	6.56e-05	0.000388	CcSEcCtD
Sevoflurane—Asthenia—Etoposide—prostate cancer	6.56e-05	0.000388	CcSEcCtD
Sevoflurane—Dyspnoea—Capecitabine—prostate cancer	6.56e-05	0.000388	CcSEcCtD
Sevoflurane—Oedema—Prednisone—prostate cancer	6.55e-05	0.000387	CcSEcCtD
Sevoflurane—Anaphylactic shock—Prednisone—prostate cancer	6.55e-05	0.000387	CcSEcCtD
Sevoflurane—Angiopathy—Epirubicin—prostate cancer	6.54e-05	0.000387	CcSEcCtD
Sevoflurane—Urethral disorder—Doxorubicin—prostate cancer	6.54e-05	0.000387	CcSEcCtD
Sevoflurane—Nausea—Mitoxantrone—prostate cancer	6.53e-05	0.000386	CcSEcCtD
Sevoflurane—Immune system disorder—Epirubicin—prostate cancer	6.51e-05	0.000385	CcSEcCtD
Sevoflurane—Mediastinal disorder—Epirubicin—prostate cancer	6.5e-05	0.000384	CcSEcCtD
Sevoflurane—Pain—Docetaxel—prostate cancer	6.5e-05	0.000384	CcSEcCtD
Sevoflurane—Chills—Epirubicin—prostate cancer	6.47e-05	0.000383	CcSEcCtD
Sevoflurane—Pruritus—Etoposide—prostate cancer	6.47e-05	0.000382	CcSEcCtD
Sevoflurane—Shock—Prednisone—prostate cancer	6.44e-05	0.000381	CcSEcCtD
Sevoflurane—Arrhythmia—Epirubicin—prostate cancer	6.44e-05	0.000381	CcSEcCtD
Sevoflurane—Nervous system disorder—Prednisone—prostate cancer	6.42e-05	0.00038	CcSEcCtD
Sevoflurane—Tachycardia—Prednisone—prostate cancer	6.39e-05	0.000378	CcSEcCtD
Sevoflurane—Skin disorder—Prednisone—prostate cancer	6.36e-05	0.000376	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Capecitabine—prostate cancer	6.35e-05	0.000375	CcSEcCtD
Sevoflurane—Mental disorder—Epirubicin—prostate cancer	6.32e-05	0.000374	CcSEcCtD
Sevoflurane—Pain—Capecitabine—prostate cancer	6.29e-05	0.000372	CcSEcCtD
Sevoflurane—Malnutrition—Epirubicin—prostate cancer	6.28e-05	0.000371	CcSEcCtD
Sevoflurane—Feeling abnormal—Docetaxel—prostate cancer	6.26e-05	0.00037	CcSEcCtD
Sevoflurane—Cardiac disorder—Doxorubicin—prostate cancer	6.19e-05	0.000366	CcSEcCtD
Sevoflurane—Tension—Epirubicin—prostate cancer	6.16e-05	0.000364	CcSEcCtD
Sevoflurane—Dysgeusia—Epirubicin—prostate cancer	6.15e-05	0.000363	CcSEcCtD
Sevoflurane—Nervousness—Epirubicin—prostate cancer	6.1e-05	0.000361	CcSEcCtD
Sevoflurane—Feeling abnormal—Capecitabine—prostate cancer	6.06e-05	0.000358	CcSEcCtD
Sevoflurane—Angiopathy—Doxorubicin—prostate cancer	6.05e-05	0.000358	CcSEcCtD
Sevoflurane—Dizziness—Etoposide—prostate cancer	6.04e-05	0.000357	CcSEcCtD
Sevoflurane—Immune system disorder—Doxorubicin—prostate cancer	6.03e-05	0.000356	CcSEcCtD
Sevoflurane—Mediastinal disorder—Doxorubicin—prostate cancer	6.01e-05	0.000356	CcSEcCtD
Sevoflurane—Body temperature increased—Docetaxel—prostate cancer	6e-05	0.000355	CcSEcCtD
Sevoflurane—Chills—Doxorubicin—prostate cancer	5.99e-05	0.000354	CcSEcCtD
Sevoflurane—Arrhythmia—Doxorubicin—prostate cancer	5.96e-05	0.000352	CcSEcCtD
Sevoflurane—Insomnia—Prednisone—prostate cancer	5.92e-05	0.00035	CcSEcCtD
Sevoflurane—Mental disorder—Doxorubicin—prostate cancer	5.85e-05	0.000346	CcSEcCtD
Sevoflurane—Urticaria—Capecitabine—prostate cancer	5.84e-05	0.000345	CcSEcCtD
Sevoflurane—Body temperature increased—Capecitabine—prostate cancer	5.81e-05	0.000344	CcSEcCtD
Sevoflurane—Vomiting—Etoposide—prostate cancer	5.81e-05	0.000344	CcSEcCtD
Sevoflurane—Malnutrition—Doxorubicin—prostate cancer	5.81e-05	0.000343	CcSEcCtD
Sevoflurane—Agitation—Epirubicin—prostate cancer	5.77e-05	0.000341	CcSEcCtD
Sevoflurane—Rash—Etoposide—prostate cancer	5.76e-05	0.000341	CcSEcCtD
Sevoflurane—Dermatitis—Etoposide—prostate cancer	5.76e-05	0.00034	CcSEcCtD
Sevoflurane—Headache—Etoposide—prostate cancer	5.73e-05	0.000339	CcSEcCtD
Sevoflurane—Tension—Doxorubicin—prostate cancer	5.7e-05	0.000337	CcSEcCtD
Sevoflurane—Dysgeusia—Doxorubicin—prostate cancer	5.69e-05	0.000336	CcSEcCtD
Sevoflurane—Nervousness—Doxorubicin—prostate cancer	5.64e-05	0.000334	CcSEcCtD
Sevoflurane—Syncope—Epirubicin—prostate cancer	5.63e-05	0.000333	CcSEcCtD
Sevoflurane—Hypersensitivity—Docetaxel—prostate cancer	5.6e-05	0.000331	CcSEcCtD
Sevoflurane—Loss of consciousness—Epirubicin—prostate cancer	5.52e-05	0.000326	CcSEcCtD
Sevoflurane—Cough—Epirubicin—prostate cancer	5.48e-05	0.000324	CcSEcCtD
Sevoflurane—Asthenia—Docetaxel—prostate cancer	5.45e-05	0.000322	CcSEcCtD
Sevoflurane—Convulsion—Epirubicin—prostate cancer	5.44e-05	0.000322	CcSEcCtD
Sevoflurane—Nausea—Etoposide—prostate cancer	5.43e-05	0.000321	CcSEcCtD
Sevoflurane—Hypertension—Epirubicin—prostate cancer	5.42e-05	0.00032	CcSEcCtD
Sevoflurane—Hypersensitivity—Capecitabine—prostate cancer	5.42e-05	0.00032	CcSEcCtD
Sevoflurane—Feeling abnormal—Prednisone—prostate cancer	5.4e-05	0.000319	CcSEcCtD
Sevoflurane—Pruritus—Docetaxel—prostate cancer	5.37e-05	0.000318	CcSEcCtD
Sevoflurane—Chest pain—Epirubicin—prostate cancer	5.34e-05	0.000316	CcSEcCtD
Sevoflurane—Agitation—Doxorubicin—prostate cancer	5.34e-05	0.000316	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	5.31e-05	0.000314	CcSEcCtD
Sevoflurane—Asthenia—Capecitabine—prostate cancer	5.28e-05	0.000312	CcSEcCtD
Sevoflurane—Dry mouth—Epirubicin—prostate cancer	5.23e-05	0.000309	CcSEcCtD
Sevoflurane—Syncope—Doxorubicin—prostate cancer	5.21e-05	0.000308	CcSEcCtD
Sevoflurane—Urticaria—Prednisone—prostate cancer	5.2e-05	0.000308	CcSEcCtD
Sevoflurane—Pruritus—Capecitabine—prostate cancer	5.2e-05	0.000308	CcSEcCtD
Sevoflurane—Body temperature increased—Prednisone—prostate cancer	5.18e-05	0.000306	CcSEcCtD
Sevoflurane—Confusional state—Epirubicin—prostate cancer	5.17e-05	0.000305	CcSEcCtD
Sevoflurane—Anaphylactic shock—Epirubicin—prostate cancer	5.12e-05	0.000303	CcSEcCtD
Sevoflurane—Oedema—Epirubicin—prostate cancer	5.12e-05	0.000303	CcSEcCtD
Sevoflurane—Loss of consciousness—Doxorubicin—prostate cancer	5.11e-05	0.000302	CcSEcCtD
Sevoflurane—Cough—Doxorubicin—prostate cancer	5.07e-05	0.0003	CcSEcCtD
Sevoflurane—Shock—Epirubicin—prostate cancer	5.04e-05	0.000298	CcSEcCtD
Sevoflurane—Convulsion—Doxorubicin—prostate cancer	5.03e-05	0.000298	CcSEcCtD
Sevoflurane—Nervous system disorder—Epirubicin—prostate cancer	5.02e-05	0.000297	CcSEcCtD
Sevoflurane—Dizziness—Docetaxel—prostate cancer	5.02e-05	0.000297	CcSEcCtD
Sevoflurane—Thrombocytopenia—Epirubicin—prostate cancer	5.02e-05	0.000297	CcSEcCtD
Sevoflurane—Hypertension—Doxorubicin—prostate cancer	5.01e-05	0.000297	CcSEcCtD
Sevoflurane—Tachycardia—Epirubicin—prostate cancer	5e-05	0.000296	CcSEcCtD
Sevoflurane—Skin disorder—Epirubicin—prostate cancer	4.98e-05	0.000294	CcSEcCtD
Sevoflurane—Chest pain—Doxorubicin—prostate cancer	4.95e-05	0.000292	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	4.91e-05	0.00029	CcSEcCtD
Sevoflurane—Dizziness—Capecitabine—prostate cancer	4.86e-05	0.000288	CcSEcCtD
Sevoflurane—Dry mouth—Doxorubicin—prostate cancer	4.84e-05	0.000286	CcSEcCtD
Sevoflurane—Vomiting—Docetaxel—prostate cancer	4.83e-05	0.000286	CcSEcCtD
Sevoflurane—Hypersensitivity—Prednisone—prostate cancer	4.83e-05	0.000285	CcSEcCtD
Sevoflurane—Rash—Docetaxel—prostate cancer	4.79e-05	0.000283	CcSEcCtD
Sevoflurane—Hypotension—Epirubicin—prostate cancer	4.79e-05	0.000283	CcSEcCtD
Sevoflurane—Dermatitis—Docetaxel—prostate cancer	4.78e-05	0.000283	CcSEcCtD
Sevoflurane—Confusional state—Doxorubicin—prostate cancer	4.78e-05	0.000283	CcSEcCtD
Sevoflurane—Headache—Docetaxel—prostate cancer	4.76e-05	0.000281	CcSEcCtD
Sevoflurane—Anaphylactic shock—Doxorubicin—prostate cancer	4.74e-05	0.00028	CcSEcCtD
Sevoflurane—Oedema—Doxorubicin—prostate cancer	4.74e-05	0.00028	CcSEcCtD
Sevoflurane—Asthenia—Prednisone—prostate cancer	4.7e-05	0.000278	CcSEcCtD
Sevoflurane—Vomiting—Capecitabine—prostate cancer	4.68e-05	0.000276	CcSEcCtD
Sevoflurane—Shock—Doxorubicin—prostate cancer	4.66e-05	0.000276	CcSEcCtD
Sevoflurane—Nervous system disorder—Doxorubicin—prostate cancer	4.65e-05	0.000275	CcSEcCtD
Sevoflurane—Thrombocytopenia—Doxorubicin—prostate cancer	4.64e-05	0.000274	CcSEcCtD
Sevoflurane—Rash—Capecitabine—prostate cancer	4.64e-05	0.000274	CcSEcCtD
Sevoflurane—Pruritus—Prednisone—prostate cancer	4.63e-05	0.000274	CcSEcCtD
Sevoflurane—Insomnia—Epirubicin—prostate cancer	4.63e-05	0.000274	CcSEcCtD
Sevoflurane—Dermatitis—Capecitabine—prostate cancer	4.63e-05	0.000274	CcSEcCtD
Sevoflurane—Tachycardia—Doxorubicin—prostate cancer	4.63e-05	0.000274	CcSEcCtD
Sevoflurane—Headache—Capecitabine—prostate cancer	4.61e-05	0.000272	CcSEcCtD
Sevoflurane—Skin disorder—Doxorubicin—prostate cancer	4.6e-05	0.000272	CcSEcCtD
Sevoflurane—Dyspnoea—Epirubicin—prostate cancer	4.57e-05	0.00027	CcSEcCtD
Sevoflurane—Somnolence—Epirubicin—prostate cancer	4.55e-05	0.000269	CcSEcCtD
Sevoflurane—Nausea—Docetaxel—prostate cancer	4.51e-05	0.000267	CcSEcCtD
Sevoflurane—Hypotension—Doxorubicin—prostate cancer	4.43e-05	0.000262	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Epirubicin—prostate cancer	4.42e-05	0.000262	CcSEcCtD
Sevoflurane—Pain—Epirubicin—prostate cancer	4.38e-05	0.000259	CcSEcCtD
Sevoflurane—Nausea—Capecitabine—prostate cancer	4.37e-05	0.000258	CcSEcCtD
Sevoflurane—Dizziness—Prednisone—prostate cancer	4.33e-05	0.000256	CcSEcCtD
Sevoflurane—Insomnia—Doxorubicin—prostate cancer	4.29e-05	0.000254	CcSEcCtD
Sevoflurane—Dyspnoea—Doxorubicin—prostate cancer	4.23e-05	0.00025	CcSEcCtD
Sevoflurane—Feeling abnormal—Epirubicin—prostate cancer	4.22e-05	0.00025	CcSEcCtD
Sevoflurane—Somnolence—Doxorubicin—prostate cancer	4.21e-05	0.000249	CcSEcCtD
Sevoflurane—Vomiting—Prednisone—prostate cancer	4.17e-05	0.000246	CcSEcCtD
Sevoflurane—Rash—Prednisone—prostate cancer	4.13e-05	0.000244	CcSEcCtD
Sevoflurane—Dermatitis—Prednisone—prostate cancer	4.13e-05	0.000244	CcSEcCtD
Sevoflurane—Headache—Prednisone—prostate cancer	4.1e-05	0.000243	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.09e-05	0.000242	CcSEcCtD
Sevoflurane—Urticaria—Epirubicin—prostate cancer	4.07e-05	0.000241	CcSEcCtD
Sevoflurane—Pain—Doxorubicin—prostate cancer	4.05e-05	0.00024	CcSEcCtD
Sevoflurane—Body temperature increased—Epirubicin—prostate cancer	4.05e-05	0.000239	CcSEcCtD
Sevoflurane—Feeling abnormal—Doxorubicin—prostate cancer	3.91e-05	0.000231	CcSEcCtD
Sevoflurane—Nausea—Prednisone—prostate cancer	3.89e-05	0.00023	CcSEcCtD
Sevoflurane—Hypersensitivity—Epirubicin—prostate cancer	3.77e-05	0.000223	CcSEcCtD
Sevoflurane—Urticaria—Doxorubicin—prostate cancer	3.77e-05	0.000223	CcSEcCtD
Sevoflurane—Body temperature increased—Doxorubicin—prostate cancer	3.75e-05	0.000222	CcSEcCtD
Sevoflurane—Asthenia—Epirubicin—prostate cancer	3.68e-05	0.000217	CcSEcCtD
Sevoflurane—Pruritus—Epirubicin—prostate cancer	3.62e-05	0.000214	CcSEcCtD
Sevoflurane—Hypersensitivity—Doxorubicin—prostate cancer	3.49e-05	0.000207	CcSEcCtD
Sevoflurane—Asthenia—Doxorubicin—prostate cancer	3.4e-05	0.000201	CcSEcCtD
Sevoflurane—Dizziness—Epirubicin—prostate cancer	3.39e-05	0.0002	CcSEcCtD
Sevoflurane—Pruritus—Doxorubicin—prostate cancer	3.35e-05	0.000198	CcSEcCtD
Sevoflurane—Vomiting—Epirubicin—prostate cancer	3.26e-05	0.000193	CcSEcCtD
Sevoflurane—Rash—Epirubicin—prostate cancer	3.23e-05	0.000191	CcSEcCtD
Sevoflurane—Dermatitis—Epirubicin—prostate cancer	3.23e-05	0.000191	CcSEcCtD
Sevoflurane—Headache—Epirubicin—prostate cancer	3.21e-05	0.00019	CcSEcCtD
Sevoflurane—Dizziness—Doxorubicin—prostate cancer	3.13e-05	0.000185	CcSEcCtD
Sevoflurane—Nausea—Epirubicin—prostate cancer	3.04e-05	0.00018	CcSEcCtD
Sevoflurane—Vomiting—Doxorubicin—prostate cancer	3.01e-05	0.000178	CcSEcCtD
Sevoflurane—Rash—Doxorubicin—prostate cancer	2.99e-05	0.000177	CcSEcCtD
Sevoflurane—Dermatitis—Doxorubicin—prostate cancer	2.99e-05	0.000177	CcSEcCtD
Sevoflurane—Headache—Doxorubicin—prostate cancer	2.97e-05	0.000176	CcSEcCtD
Sevoflurane—Nausea—Doxorubicin—prostate cancer	2.82e-05	0.000166	CcSEcCtD
Sevoflurane—CYP2E1—Metabolism—CYP2A6—prostate cancer	4.29e-06	3.84e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SULT2A1—prostate cancer	4.29e-06	3.84e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—AKR1C3—prostate cancer	4.26e-06	3.81e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PRKACB—prostate cancer	4.24e-06	3.79e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GGT1—prostate cancer	4.24e-06	3.79e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—MED12—prostate cancer	4.22e-06	3.77e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP17A1—prostate cancer	4.2e-06	3.75e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GNG5—prostate cancer	4.19e-06	3.74e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NCOA1—prostate cancer	4.18e-06	3.73e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—AKR1C3—prostate cancer	4.17e-06	3.73e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PRKACB—prostate cancer	4.15e-06	3.71e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYP19A1—prostate cancer	4.11e-06	3.68e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP17A1—prostate cancer	4.11e-06	3.67e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—CREBBP—prostate cancer	4.04e-06	3.61e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NCOA3—prostate cancer	4.03e-06	3.61e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—HPGD—prostate cancer	4.03e-06	3.6e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—B4GALT4—prostate cancer	4.03e-06	3.6e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NCOA2—prostate cancer	4e-06	3.58e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IGF1—prostate cancer	3.98e-06	3.56e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—RXRA—prostate cancer	3.97e-06	3.55e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.96e-06	3.54e-05	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	3.94e-06	3.53e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NCOA2—prostate cancer	3.92e-06	3.5e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—HPGDS—prostate cancer	3.85e-06	3.44e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CD—prostate cancer	3.83e-06	3.42e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—COMT—prostate cancer	3.83e-06	3.42e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP2C19—prostate cancer	3.82e-06	3.42e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SLC5A5—prostate cancer	3.81e-06	3.41e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTP1—prostate cancer	3.81e-06	3.41e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TNFRSF21—prostate cancer	3.79e-06	3.39e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—SERPINE1—prostate cancer	3.78e-06	3.38e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ITPR1—prostate cancer	3.75e-06	3.35e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SLC5A5—prostate cancer	3.74e-06	3.34e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTT1—prostate cancer	3.73e-06	3.34e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ACHE—prostate cancer	3.73e-06	3.34e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP2E1—prostate cancer	3.73e-06	3.33e-05	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—AKT1—prostate cancer	3.7e-06	3.31e-05	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—AKT1—prostate cancer	3.7e-06	3.31e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP2A6—prostate cancer	3.69e-06	3.3e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—MTAP—prostate cancer	3.69e-06	3.3e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP7B1—prostate cancer	3.69e-06	3.3e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NQO1—prostate cancer	3.68e-06	3.29e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.67e-06	3.29e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—TH—prostate cancer	3.63e-06	3.25e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—NOS3—prostate cancer	3.61e-06	3.23e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NQO1—prostate cancer	3.61e-06	3.23e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SULT1E1—prostate cancer	3.59e-06	3.21e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SRD5A1—prostate cancer	3.59e-06	3.21e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP3A4—prostate cancer	3.59e-06	3.21e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—AKR1C3—prostate cancer	3.59e-06	3.21e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PRKACB—prostate cancer	3.57e-06	3.19e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—TH—prostate cancer	3.56e-06	3.18e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—TYMS—prostate cancer	3.54e-06	3.17e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP17A1—prostate cancer	3.53e-06	3.16e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP1B1—prostate cancer	3.53e-06	3.16e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP3A4—prostate cancer	3.52e-06	3.15e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—JAK2—prostate cancer	3.51e-06	3.14e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTM1—prostate cancer	3.5e-06	3.13e-05	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.49e-06	3.12e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.48e-06	3.12e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP1B1—prostate cancer	3.46e-06	3.09e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—LPL—prostate cancer	3.43e-06	3.07e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ACSL4—prostate cancer	3.43e-06	3.07e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—HSD17B3—prostate cancer	3.43e-06	3.07e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GGT1—prostate cancer	3.42e-06	3.06e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NCOA1—prostate cancer	3.37e-06	3.01e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NCOA2—prostate cancer	3.37e-06	3.01e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GGT1—prostate cancer	3.35e-06	3e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CB—prostate cancer	3.33e-06	2.98e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP19A1—prostate cancer	3.32e-06	2.97e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYP1A1—prostate cancer	3.32e-06	2.97e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NCOA1—prostate cancer	3.3e-06	2.95e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ERCC2—prostate cancer	3.29e-06	2.94e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PHGDH—prostate cancer	3.29e-06	2.94e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ARG2—prostate cancer	3.29e-06	2.94e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—UMPS—prostate cancer	3.29e-06	2.94e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP19A1—prostate cancer	3.25e-06	2.91e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—LDHB—prostate cancer	3.22e-06	2.88e-05	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	3.22e-06	2.88e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SLC5A5—prostate cancer	3.21e-06	2.87e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—RXRA—prostate cancer	3.2e-06	2.87e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP3A5—prostate cancer	3.16e-06	2.83e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—RXRA—prostate cancer	3.14e-06	2.81e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP2E1—prostate cancer	3.14e-06	2.8e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NQO1—prostate cancer	3.1e-06	2.77e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—MTHFR—prostate cancer	3.09e-06	2.77e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—COMT—prostate cancer	3.09e-06	2.76e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTP1—prostate cancer	3.07e-06	2.75e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IL2—prostate cancer	3.06e-06	2.74e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—TH—prostate cancer	3.06e-06	2.73e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PDHA1—prostate cancer	3.05e-06	2.73e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—UCP3—prostate cancer	3.05e-06	2.73e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TCN2—prostate cancer	3.05e-06	2.73e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTA3—prostate cancer	3.05e-06	2.73e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.04e-06	2.72e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PPARA—prostate cancer	3.03e-06	2.71e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP3A4—prostate cancer	3.02e-06	2.7e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—COMT—prostate cancer	3.02e-06	2.7e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ITPR1—prostate cancer	3.02e-06	2.7e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTP1—prostate cancer	3.01e-06	2.69e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.01e-06	2.69e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP1B1—prostate cancer	2.97e-06	2.66e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ITPR1—prostate cancer	2.96e-06	2.65e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.91e-06	2.61e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.91e-06	2.61e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GGT1—prostate cancer	2.88e-06	2.57e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—TYMS—prostate cancer	2.86e-06	2.55e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CAV1—prostate cancer	2.85e-06	2.55e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NCOA1—prostate cancer	2.84e-06	2.54e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTM1—prostate cancer	2.82e-06	2.52e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—TYMS—prostate cancer	2.8e-06	2.5e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP19A1—prostate cancer	2.79e-06	2.5e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTA4—prostate cancer	2.79e-06	2.5e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.79e-06	2.5e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—LPL—prostate cancer	2.77e-06	2.48e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTM1—prostate cancer	2.77e-06	2.47e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—EP300—prostate cancer	2.75e-06	2.46e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTA2—prostate cancer	2.72e-06	2.43e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—LPL—prostate cancer	2.71e-06	2.43e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—RXRA—prostate cancer	2.7e-06	2.41e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ABCG5—prostate cancer	2.69e-06	2.41e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.69e-06	2.41e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP1A1—prostate cancer	2.68e-06	2.39e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—SRC—prostate cancer	2.67e-06	2.39e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ERCC2—prostate cancer	2.65e-06	2.37e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTA1—prostate cancer	2.63e-06	2.35e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.62e-06	2.35e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP1A1—prostate cancer	2.62e-06	2.34e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—VEGFA—prostate cancer	2.6e-06	2.33e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ERCC2—prostate cancer	2.6e-06	2.33e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—COMT—prostate cancer	2.6e-06	2.32e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CG—prostate cancer	2.6e-06	2.32e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NAT2—prostate cancer	2.6e-06	2.32e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.6e-06	2.32e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTO1—prostate cancer	2.6e-06	2.32e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTP1—prostate cancer	2.59e-06	2.31e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ITPR1—prostate cancer	2.54e-06	2.28e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.5e-06	2.24e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—MTHFR—prostate cancer	2.49e-06	2.23e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PLCB2—prostate cancer	2.49e-06	2.23e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—LRP2—prostate cancer	2.49e-06	2.23e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.49e-06	2.23e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—INS—prostate cancer	2.46e-06	2.2e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PPARA—prostate cancer	2.45e-06	2.19e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—MTHFR—prostate cancer	2.44e-06	2.19e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—P4HB—prostate cancer	2.44e-06	2.18e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CREBBP—prostate cancer	2.41e-06	2.15e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—TYMS—prostate cancer	2.4e-06	2.15e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PPARA—prostate cancer	2.4e-06	2.14e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TGFB1—prostate cancer	2.39e-06	2.14e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTM1—prostate cancer	2.38e-06	2.13e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.38e-06	2.12e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—LPL—prostate cancer	2.33e-06	2.09e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.32e-06	2.07e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CAV1—prostate cancer	2.3e-06	2.06e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CD—prostate cancer	2.28e-06	2.04e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—MED12—prostate cancer	2.28e-06	2.04e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GNG5—prostate cancer	2.26e-06	2.02e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CAV1—prostate cancer	2.25e-06	2.02e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP1A1—prostate cancer	2.25e-06	2.01e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ERCC2—prostate cancer	2.23e-06	2e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—KRAS—prostate cancer	2.21e-06	1.98e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NCOA3—prostate cancer	2.18e-06	1.95e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NOS3—prostate cancer	2.16e-06	1.93e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—MTHFR—prostate cancer	2.1e-06	1.88e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CG—prostate cancer	2.1e-06	1.87e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—HPGDS—prostate cancer	2.08e-06	1.86e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.06e-06	1.85e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PPARA—prostate cancer	2.06e-06	1.84e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CG—prostate cancer	2.05e-06	1.84e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CA—prostate cancer	2.03e-06	1.82e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ACHE—prostate cancer	2.01e-06	1.8e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTT1—prostate cancer	2.01e-06	1.8e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.99e-06	1.78e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CB—prostate cancer	1.99e-06	1.78e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—INS—prostate cancer	1.98e-06	1.77e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTGS2—prostate cancer	1.97e-06	1.76e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TP53—prostate cancer	1.97e-06	1.76e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CREBBP—prostate cancer	1.94e-06	1.74e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—INS—prostate cancer	1.94e-06	1.74e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CAV1—prostate cancer	1.94e-06	1.73e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.94e-06	1.73e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PRKACB—prostate cancer	1.93e-06	1.72e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.91e-06	1.7e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CREBBP—prostate cancer	1.9e-06	1.7e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.85e-06	1.66e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CD—prostate cancer	1.84e-06	1.65e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NCOA2—prostate cancer	1.82e-06	1.62e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CD—prostate cancer	1.8e-06	1.61e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CG—prostate cancer	1.76e-06	1.58e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NOS3—prostate cancer	1.74e-06	1.56e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.73e-06	1.55e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTEN—prostate cancer	1.72e-06	1.54e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NOS3—prostate cancer	1.7e-06	1.52e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.69e-06	1.51e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NQO1—prostate cancer	1.67e-06	1.5e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—INS—prostate cancer	1.67e-06	1.49e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—AKT1—prostate cancer	1.66e-06	1.49e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TH—prostate cancer	1.65e-06	1.48e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—EP300—prostate cancer	1.64e-06	1.47e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CREBBP—prostate cancer	1.64e-06	1.46e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CB—prostate cancer	1.61e-06	1.44e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.6e-06	1.44e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTGS2—prostate cancer	1.59e-06	1.42e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CB—prostate cancer	1.57e-06	1.41e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTGS2—prostate cancer	1.56e-06	1.39e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GGT1—prostate cancer	1.55e-06	1.39e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CD—prostate cancer	1.55e-06	1.39e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NCOA1—prostate cancer	1.53e-06	1.37e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.51e-06	1.35e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NOS3—prostate cancer	1.46e-06	1.31e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—RXRA—prostate cancer	1.46e-06	1.3e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—COMT—prostate cancer	1.4e-06	1.25e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTP1—prostate cancer	1.4e-06	1.25e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTEN—prostate cancer	1.39e-06	1.24e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ITPR1—prostate cancer	1.37e-06	1.23e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTEN—prostate cancer	1.36e-06	1.22e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CB—prostate cancer	1.35e-06	1.21e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTGS2—prostate cancer	1.34e-06	1.2e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—EP300—prostate cancer	1.32e-06	1.18e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TYMS—prostate cancer	1.3e-06	1.16e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—EP300—prostate cancer	1.3e-06	1.16e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTM1—prostate cancer	1.28e-06	1.15e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—LPL—prostate cancer	1.26e-06	1.13e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.22e-06	1.09e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CA—prostate cancer	1.21e-06	1.09e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ERCC2—prostate cancer	1.21e-06	1.08e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTEN—prostate cancer	1.17e-06	1.04e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—MTHFR—prostate cancer	1.13e-06	1.01e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—EP300—prostate cancer	1.11e-06	9.97e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PPARA—prostate cancer	1.11e-06	9.95e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CAV1—prostate cancer	1.05e-06	9.35e-06	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—AKT1—prostate cancer	9.91e-07	8.87e-06	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CA—prostate cancer	9.79e-07	8.76e-06	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CA—prostate cancer	9.59e-07	8.58e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CG—prostate cancer	9.53e-07	8.52e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—INS—prostate cancer	9.02e-07	8.06e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CREBBP—prostate cancer	8.83e-07	7.9e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CD—prostate cancer	8.37e-07	7.49e-06	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CA—prostate cancer	8.24e-07	7.37e-06	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—AKT1—prostate cancer	8e-07	7.15e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NOS3—prostate cancer	7.91e-07	7.07e-06	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—AKT1—prostate cancer	7.83e-07	7.01e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CB—prostate cancer	7.3e-07	6.53e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTGS2—prostate cancer	7.23e-07	6.47e-06	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—AKT1—prostate cancer	6.73e-07	6.02e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTEN—prostate cancer	6.31e-07	5.64e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—EP300—prostate cancer	6.01e-07	5.38e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.45e-07	3.98e-06	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—AKT1—prostate cancer	3.63e-07	3.25e-06	CbGpPWpGaD
